Document is current
Any future updates will be listed below
-
Authors
Zhao, Chenchen
Jia, Bei
Jiang, Yixing
Shike, Hiroko
Annageldiyev, Charyguly
Cioccio, Joseph
Minagawa, Kentaro
Mineishi, Shin
Ehmann, WChristopher
Schell, Todd D.
Cheng, Hua
Zheng, Hong
-
Funding
Funding for this research was provided by:
American Cancer Society (RSG-22-140-01-IBCD)
- License Information
-
More Information
Article History
Received: 22 September 2024
Accepted: 6 February 2025
First Online: 25 February 2025
Declarations
:
: Hua Cheng is the founder for ImmuCision Biotherapeutics, LLC, which develops DC technology for profit. All other authors declare no conflicts of interest.
